Oteri, V.; Gianì, F.; Sapuppo, G.; Panebianco, S.; Marturano, I.; Blanco, G.; Malandrino, P.; Russo, M.; Frasca, F.; Pellegriti, G.
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center. Cancers 2025, 17, 2372.
https://doi.org/10.3390/cancers17142372
AMA Style
Oteri V, Gianì F, Sapuppo G, Panebianco S, Marturano I, Blanco G, Malandrino P, Russo M, Frasca F, Pellegriti G.
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center. Cancers. 2025; 17(14):2372.
https://doi.org/10.3390/cancers17142372
Chicago/Turabian Style
Oteri, Vittorio, Fiorenza Gianì, Giulia Sapuppo, Stefania Panebianco, Ilenia Marturano, Giusi Blanco, Pasqualino Malandrino, Marco Russo, Francesco Frasca, and Gabriella Pellegriti.
2025. "Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center" Cancers 17, no. 14: 2372.
https://doi.org/10.3390/cancers17142372
APA Style
Oteri, V., Gianì, F., Sapuppo, G., Panebianco, S., Marturano, I., Blanco, G., Malandrino, P., Russo, M., Frasca, F., & Pellegriti, G.
(2025). Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center. Cancers, 17(14), 2372.
https://doi.org/10.3390/cancers17142372
